secwatch.observer — SEC 8-K summary
======================================

Issuer:     Actinium Pharmaceuticals, Inc. (ATNM)
CIK:        0001388320
Form:       8-K
Filed at:   2021-11-09T23:59:59+00:00
Accession:  0001213900-21-057769
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Actinium shareholders re-elect two Class II directors; approve 2.75M share increase to 2019 Plan
--------------------------------------------------------------------------------

- Sandesh Seth and Jeffrey W. Chell re-elected as Class II directors for term expiring at 2024 annual meeting.
- Shareholders approved Second Amendment to 2019 Plan, increasing available shares by 2,750,000 to total 5,833,333.
- Marcum LLP ratified as independent auditor for FY 2021 with 12,371,473 votes for.
- Broker non-votes totaled 6,568,275 on director elections and plan amendment.
- Annual meeting had 12,755,273 shares present; no other matters were voted on.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1388320/000121390021057769/0001213900-21-057769-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1388320/000121390021057769/ea150278-8k_actiniumph.htm
  HTML page:      https://secwatch.observer/filing/0001213900-21-057769

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer